PharmaForce International: Updated User-Friendly Dashboard Allows for Five Year Trending of Oncology Commercialization FTEs

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

READING, Pa., Nov. 19, 2020 /PRNewswire/ — PharmaForce International (PFI) has recently updated a dashboard that allows users to confidently sort and compare United States Oncology full-time equivalents (FTEs) among over 70 indications across promoted brands. The purpose of the US Oncology trends dashboard is to enable competing oncology companies to strengthen their 2021 commercial strategies by easily comparing data trends over time. This dashboard contains data from 2016 to 2020, and allows users to compare the following deliverables by year:

  • The number of Commercial Oncology FTEs
  • The number of Sales FTEs by product/brand
  • The number of Sales FTEs by indication
  • The number of Sales FTEs by indication and company
  • The number of Biomarker/Pathology FTEs by company
  • The number of CAR-T FTEs by company
  • The top 10 FTE allocations by company, indication, and product

For more US Dashboard content, please visit: https://bit.ly/36CpVpK

In addition to the United States, PFI has also updated an Oncology trends dashboard for the five major European countries (France, Germany, Italy, Spain, and the United Kingdom). This dashboard is now available for purchase. With the addition of sorting by country, the EU5 dashboard has similar features – such as sorting by year, company, and product/brand.

For more information on the dashboards mentioned above, please contact Joyce Wedemeyer at Joyce.Wedemeyer@pharmaforceintl.com or by phone at 610-370-2906.

PharmaForce International (PFI) is a competitive intelligence firm with over two decades of experience in the pharmaceutical and biotech industries. PFI has become the market leader in commercial operations benchmarking and competitive intelligence.

View original content to download multimedia:http://www.prnewswire.com/news-releases/pharmaforce-international-updated-user-friendly-dashboard-allows-for-five-year-trending-of-oncology-commercialization-ftes-301177388.html

SOURCE PharmaForce International

Staff

Recent Posts

Maria Ansari, MD, FACC, named to Modern Healthcare’s list of 50 Most Influential Clinical Executives

Co-CEO of The Permanente Federation and leader of multiple Permanente Medical Groups at Kaiser Permanente,…

3 hours ago

Dignify Therapeutics Announces Jeff Welch as Chief Operating Officer

RESEARCH TRIANGLE PARK, N.C., June 12, 2025 /PRNewswire/ -- Dignify Therapeutics (Dignify), a pharmaceutical and medical…

3 hours ago

Transforming Communication in the Workplace and Beyond: Glodean Champion Launches “The Process to LOVE™” – A Revolutionary Communication Framework for Human-Centered Leadership

CHICAGO, June 12, 2025 /PRNewswire/ -- Workplace miscommunication costs businesses an estimated $1.2 trillion annually and…

3 hours ago

THE MERCY SHIPS to Launch Exclusively on Angel.com and the Angel App. First Three Episodes to Stream Free of Charge

Step aboard the world's largest civilian-run hospital ships and witness stories of compassion, courage, and…

3 hours ago

LabConnect Selects Deloitte to Streamline Financial and Business Operations

JOHNSON CITY, Tenn., June 12, 2025 /PRNewswire/ -- LabConnect, a leading provider of global central…

9 hours ago

BUDS Technology Transforms Senior Care with AKSSI Virtual Nurse Assistant

ROSWELL, Ga., June 12, 2025 /PRNewswire/ -- Buds Technology, a leading innovator in healthcare solutions, has…

9 hours ago